Oligodendrocyte precursor cell proliferation regulated by...

Details Oligodendrocyte precursor cell proliferation regulated by... Oligodendrocyte precursor cell proliferation regulated by...

2011-06-21

2011-06-21

Romeo, David S (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S007600, C514S009700, C514S017900, C514S001100, C435S377000

Reexamination Certificate

active

07964563

ABSTRACT:
The present invention relates to a method to increase oligodendrocytes and oligodendrocyte precursor cells through administration of prolactin or a prolactin inducing agent.

REFERENCES:
patent: 4703008 (1987-10-01), Lin
patent: 4767628 (1988-08-01), Hutchinson
patent: 4801575 (1989-01-01), Pardridge
patent: 4902680 (1990-02-01), Aroonsakul
patent: 5023252 (1991-06-01), Hseih
patent: 5128242 (1992-07-01), Arimura et al.
patent: 5198542 (1993-03-01), Onda et al.
patent: 5208320 (1993-05-01), Kitada et al.
patent: 5231178 (1993-07-01), Holtz et al.
patent: 5268164 (1993-12-01), Kozarich et al.
patent: 5326860 (1994-07-01), Onda et al.
patent: 5441868 (1995-08-01), Lin
patent: 5473054 (1995-12-01), Jameson
patent: 5505206 (1996-04-01), Walloch
patent: 5506107 (1996-04-01), Cunningham et al.
patent: 5521069 (1996-05-01), Onda et al.
patent: 5527527 (1996-06-01), Friden
patent: 5547935 (1996-08-01), Mullenbach et al.
patent: 5547993 (1996-08-01), Miki
patent: 5559143 (1996-09-01), McDonald
patent: 5614184 (1997-03-01), Sytkowski et al.
patent: 5621080 (1997-04-01), Lin
patent: 5623050 (1997-04-01), Kitada et al.
patent: 5686416 (1997-11-01), Kozarich
patent: 5723115 (1998-03-01), Serrero
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Johe
patent: 5773569 (1998-06-01), Wrighton et al.
patent: 5795790 (1998-08-01), Shinstine et al.
patent: 5801147 (1998-09-01), Kitada et al.
patent: 5833988 (1998-11-01), Friden
patent: 5837460 (1998-11-01), Von Feldt et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 5877169 (1999-03-01), Simpkins
patent: 5885574 (1999-03-01), Elliott
patent: 5955346 (1999-09-01), Wells et al.
patent: 5977307 (1999-11-01), Friden et al.
patent: 5980885 (1999-11-01), Weiss et al.
patent: 6015555 (2000-01-01), Friden
patent: 6017533 (2000-01-01), Moro et al.
patent: 6048971 (2000-04-01), Sytkowski et al.
patent: 6165783 (2000-12-01), Weiss et al.
patent: 6191106 (2001-02-01), Mullenbach et al.
patent: 6239105 (2001-05-01), Brewitt
patent: 6294346 (2001-09-01), Weiss et al.
patent: 6329508 (2001-12-01), Friden
patent: 6333031 (2001-12-01), Olsson et al.
patent: 6376218 (2002-04-01), Hsu et al.
patent: 6395546 (2002-05-01), Zobel et al.
patent: 6399316 (2002-06-01), Onda et al.
patent: 6413952 (2002-07-01), Luengo et al.
patent: 6429186 (2002-08-01), Fuh et al.
patent: 6551618 (2003-04-01), Baird et al.
patent: 6618698 (2003-09-01), Beausoleil et al.
patent: 6680295 (2004-01-01), Arimura
patent: 6797264 (2004-09-01), Eriksson
patent: 6812027 (2004-11-01), Goldman et al.
patent: 7048934 (2006-05-01), Thompson et al.
patent: 7132287 (2006-11-01), Rajan et al.
patent: 7368115 (2008-05-01), Ohta et al.
patent: 7393830 (2008-07-01), Shingo et al.
patent: 7514072 (2009-04-01), Ehrenreich et al.
patent: 7534765 (2009-05-01), Gregg et al.
patent: 2002/0098178 (2002-07-01), Brand
patent: 2003/0032181 (2003-02-01), Weiss et al.
patent: 2003/0049838 (2003-03-01), Thompson et al.
patent: 2003/0054551 (2003-03-01), Shingo et al.
patent: 2003/0054998 (2003-03-01), Shingo et al.
patent: 2003/0130197 (2003-07-01), Smith-Swintosky et al.
patent: 2004/0038888 (2004-02-01), Mercer et al.
patent: 2004/0092448 (2004-05-01), Ohta et al.
patent: 2004/0209000 (2004-10-01), Curtiss et al.
patent: 2004/0209812 (2004-10-01), Renzi et al.
patent: 2005/0009847 (2005-01-01), Bertilsson et al.
patent: 2005/0245436 (2005-11-01), Weiss et al.
patent: 2006/0089309 (2006-04-01), Tucker
patent: 2006/0121007 (2006-06-01), Thompson et al.
patent: 2006/0148084 (2006-07-01), Shingo et al.
patent: 2007/0098698 (2007-05-01), Gregg et al.
patent: 2007/0111932 (2007-05-01), Anderson
patent: 2007/0179092 (2007-08-01), Ohta et al.
patent: 2008/0039389 (2008-02-01), Weiss et al.
patent: 2008/0181873 (2008-07-01), Shingo et al.
patent: 2008/0286234 (2008-11-01), Eyink
patent: 2009/0274668 (2009-11-01), Thompson et al.
patent: 2010/0028361 (2010-02-01), Smith et al.
patent: 2010/0047233 (2010-02-01), Smith et al.
patent: 2175992 (1995-05-01), None
patent: 2353553 (2000-06-01), None
patent: 2556266 (2005-08-01), None
patent: 0456279 (1991-11-01), None
patent: 0467279 (1992-01-01), None
patent: WO 90 05185 (1990-05-01), None
patent: WO 93 01275 (1993-01-01), None
patent: WO 94 09119 (1994-04-01), None
patent: WO 94 10292 (1994-05-01), None
patent: WO 96 09318 (1996-03-01), None
patent: WO9615226 (1996-05-01), None
patent: WO 96 40231 (1996-12-01), None
patent: WO 97 48729 (1997-12-01), None
patent: WO 99 15191 (1999-04-01), None
patent: WO 99 21966 (1999-05-01), None
patent: WO 99 51272 (1999-10-01), None
patent: WO 00 05260 (2000-02-01), None
patent: WO 00 13650 (2000-03-01), None
patent: WO 00 30675 (2000-06-01), None
patent: WO 01 28574 (2001-04-01), None
patent: WO01/59074 (2001-08-01), None
patent: WO 03 18782 (2003-03-01), None
patent: WO 03 024472 (2003-03-01), None
patent: WO 03 035475 (2003-05-01), None
patent: WO 03 40310 (2003-05-01), None
patent: WO 03 092716 (2003-11-01), None
patent: WO 2004 011021 (2004-02-01), None
patent: WO 2004 011632 (2004-02-01), None
patent: WO2004011021 (2004-02-01), None
patent: WO2004011632 (2004-02-01), None
patent: WO2006/037233 (2006-04-01), None
patent: WO 2007 106987 (2007-09-01), None
patent: WO2009/057111 (2009-05-01), None
patent: WO 2009/137874 (2009-11-01), None
Ehrenreich et al., “Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke,” Stroke. 2009;40:00-00.
Minnerup et al., “The Efficacy of Erythropoietin and Its Analogues in Animal Stroke Models: A Meta Analysis,” American Heart Association, Inc. pp. 3113-3120. 2009.
Aberg et al., “Peripheral Infusion of IGF-I Selectively Induces Neurogenesis in the Adult Rat Hippocampus.” J Neurosci., 20(8): 2896-2903 (2000).
Abramsky, O et al., “Suppressive Effect of Pregnancy on Ms and EAE” Prog. Clin. Biol. Res. 146:399-406 (1984).
Allen, J.S. et al., “Sexual dimorphism and asymmetries in the gray-white composition of the human cerebrum,” NeuroImage 18:880-894 (2003).
Al-Hader et al., “Fetal rat brains contain luteinizing hormone/human chorionic gonadotropin receptors,” Early Pregnancy Biol. And Med. 3:323-9 (1997).
Al-Hader et al, “Neurons from fetal rat brain contains functional luteinizing hormone/chorionic gonadotropin receptors,” Bio. Reprod. 56:1071-6 (1997).
Al-Hader, A. A. et al., “Novel expression of functional luteinizing hormone/chorionic gonadotropin receptors in cultured glial cells from neonatal rat brains,” Bio. of Reprod., vol. 56, pp. 501-507 (1997).
Anderson et al., “Insulin-like growth factor-I and neurogenesis in the adult mammalian brain,” Brain Res. Dev. Brain Res., 134(1-2): 115-22 (2002).
Arimura et al., “PACAP functions as a neurotophic factor,” Ann. NY Acad. Sci., 739:228-243 (1994).
Arimura, “Perspectives on pituitary adenylate cyclase activating polypeptide PACAP in the neuroendocrine, endocrine and nervous systems,” Jap. J. Physiol., 48:301-331 (1998).
Arimura et al., “Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain testes,” Endocrinology, 129:2787-9 (1991).
Arimura, “Pituitary adenylate cyclase activating polypeptide PACAP: Discovery and current status of research,” Regulatory Peptides, 37:287-303 (1992).
Arlotta P. et al, “Introduction to Adult Neurogensis,” Annals of the N. Y. Acad. of Sci., vol. 991, No. 1, pp. 229-236 (2003).
Armstrong, R.C. et al., “Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter,” J. Neurosci. 22(19): 8574-8585 (2002).
Arnett, H.A. et al., “TNFα promotes proliferation of oligodendrocyte progenitors and remyelination,” Nature 4(11:1116-22 (2001).
Arsenijevic & Weiss (Dec. 1996) “Insulin-like Growth Factor-1 IGF-I) Recruits a Distinct Population of Embryonic Neural Stem Cells.”Molecular Biology of the Cell 7 (Supplement): 1843.
Arsenijevic et al., “Insulin-like Growth Factor-I Is Nec

Affiliated with

Also associated with

Rating

Oligodendrocyte precursor cell proliferation regulated by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oligodendrocyte precursor cell proliferation regulated by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligodendrocyte precursor cell proliferation regulated by... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2742493